Social and Economic Factors in the Choice of Lung Cancer Treatment

New England Journal of Medicine

Volumn 318, Issue 10, 1988, Pages 612-617

  Greenberg, E R ^a   Chute, C G ^a   Stukel, T ^a   Baron, J A ^a   Freeman, D H ^a   Yates, J ^a   Korson, R ^a  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ECONOMIC ASPECT; HUMAN; LUNG CANCER; PRIORITY JOURNAL; REVIEW;

AGE FACTORS; AGED; CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; DECISION MAKING; FEMALE; HUMAN; INSURANCE, HEALTH; LUNG NEOPLASMS; MALE; MARRIAGE; MIDDLE AGE; NEW HAMPSHIRE; RESIDENCE CHARACTERISTICS; RETROSPECTIVE STUDIES; RURAL POPULATION; SOCIOECONOMIC FACTORS; SUPPORT, U.S. GOV'T, P.H.S.; VERMONT;

EID: 0023865263     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198803103181006     Document Type: Article

References (26)

1. Huhti E, Sultinen S, Saloheim M. Survival among patients with lung cancer: an epidemiologic study. Am Rev Respir Dis 1981; 124: 13–6.
2. Chute CG, Greenberg ER, Baron J, Korson R, Baker J, Yates J. Presenting conditions of 1539 population-based lung cancer patients by cell type and stage in New Hampshire and Vermont. Cancer 1985; 56: 2107–11.
3. Stanley KE. Prognostic factors for survival in patients with inoperable lung cancer. JNCI 1980; 65: 25–32.
4. Department of Commerce, Bureau of the Census. 1970 Census of population: characteristics of the population. Washington, D.C.: Government Printing Office, 1972.
5. Greenberg ER, Korson R, Baker J, Barrett J, Baron JA, Yates J. Incidence of lung cancer by cell type: a population-based study in New Hampshire and Vermont. JNCI 1984; 72: 599–603.
6. Karnofsky DA, Burchenal JH. The clinical evaluation of chemotherapeutic agents in cancer. In: Macleod CM, ed. Evaluation of chemotherapeutic agents: symposium, microbiology section, New York Academy of Medicine, 1948. New York: Columbia University Press, 1949:191–205.
7. Young JL Jr, Percy CL, Asire AJ. Surveillance, epidemiology, and end results: incidence and mortality data, 1973–1977. Natl Cancer Inst Monogr 1981; 57: 1–9.
8. American Joint Committee for Cancer Staging and End-Results Reporting. Staging of lung cancer. Chicago: American Joint Committee, 1979.
9. Kleinbaum DG, Kupper LL, Morgenstern H. Epidemiologic research: principles and quantitative methods. Belmont, Calif.: Lifetime Learning Publications, 1982.
10. Aitkin M. A note on the selection of log-linear models. Biometrics 1980; 36: 173–8.
11. Lee ET. Statistical methods for survival data analysis. Belmont, Calif.: Lifetime Learning Publications, 1980.
12. SAS Institute, Inc. SAS user's guide: statistics, version 5 edition. Cary, N.C.: SAS Institute, 1985.
13. Aday LA. Economic and noneconomic barriers to the use of needed medical services. Med Care 1975; 13: 447–56.
14. Davis K, Rowland D. Uninsured and underserved: inequities in health care in the United States. Milbank Mem Fund Q 1983; 61: 149–76.
15. McNeil BJ, Weichselbaum R, Pauker SG. Fallacy of the five-year survival in lung cancer. N Engl J Med 1978; 299: 1397–401.
16. Berkman LF, Syme SL. Social networks, host resistance, and mortality: a nine-year follow-up study of Alameda County residents. Am J Epidemiol 1979; 109: 186–204.
17. Berkman LF. Social networks, support, and health: taking the next step forward. Am J Epidemiol 1986; 123: 559–62.
18. Cassileth BR, Lusk EJ, Miller DS, Brown LL, Miller C. Psychosocial correlates of survival in advanced malignant disease? N Engl J Med 1985; 312: 1551–5.
19. Goodwin JS, Hunt WC, Key CR, Samet JM. The effect of marital status on stage, treatment, and survival of cancer patients. JAMA 1987; 258: 3125–30.
20. Craigen AA, Hickling JB, Saunders CRG, Carpenter RG. Natural history of prostatic obstruction. J R Coll Gen Pract 1969; 18: 226–32.
21. Jarvis E. The influence of distance from and proximity to an insane hospital, on its use by any people. Boston Med Surg J 1850; 42: 209–22.
22. Joseph AE, Phillips DR. Accessibility and utilization: geographical perspectives on health care delivery. New York: Harper & Row, 1984.
23. Donegan WL. Treatment of breast cancer in the elderly. In: Yancik R, ed. Perspectives on prevention and treatment of cancer in the elderly. New York, Raven Press, 1983:83–96.
24. Mor V, Masterson-Allen S, Goldberg RJ, Cummings FJ, Glicksman AS, Fretwell MD. Relationship between age at diagnosis and treatments received by cancer patients. J Am Geriatr Soc 1985; 33: 585–9.
25. Samet J, Hunt WC, Key C, Humble CG, Goodwin JS. Choice of cancer therapy varies with age of patient. JAMA 1986; 255: 3385–90.
26. Greenfield S, Blanco DM, Elashoff RM, Ganz PA. Patterns of care related to age of breast cancer patients. JAMA 1987; 257: 2766–70.